Designer drugs for inflammatory bowel disease

Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.

Beneficial microbes·2022

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022

Metagenomic assembled plasmids of the human microbiome vary across disease cohorts.

Scientific reports·2022

Mapping the colorectal tumor microbiota.

Gut microbes·2021

The gut virome in Irritable Bowel Syndrome differs from that of controls.

Gut microbes·2021

The fecal mycobiome in patients with Irritable Bowel Syndrome.

Scientific reports·2021

Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort.

Gastroenterology·2026

Artificial Intelligence-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically Enhanced Deep Learning.

Gastroenterology·2026

Serotonergic Signaling in Gastric Physiology and Motility Disorders.

Gastroenterology·2026

Construction of cell factories, and multi-enzymatic and chemoenzymatic cascades to enable the efficient production of alkaloids.

Natural product reports·2026

Total Synthesis of ent-Kaurenoic Acid Diterpenoids Enabled by Distal Conformational Control in Photoredox Radical Polyene Cyclization.

Angewandte Chemie (International ed. in English)·2026

Semisynthetic diversification of the fungal azaphilone austdiol highlights scaffold-encoded reactivity in natural products.

Organic & biomolecular chemistry·2026

Highly fluorescent and solvatochromic phenazine-diamines: the role of non-conjugating substituents.

Chemical communications (Cambridge, England)·2026

Carrier-free self-assembled nanoparticles derived from traditional Chinese medicine active components: construction strategies and applications.

RSC advances·2026

Related Experiment Videos

Designer drugs for inflammatory bowel disease

Related Concept Videos

Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.

Metagenomic assembled plasmids of the human microbiome vary across disease cohorts.

Mapping the colorectal tumor microbiota.

The gut virome in Irritable Bowel Syndrome differs from that of controls.

The fecal mycobiome in patients with Irritable Bowel Syndrome.

Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort.

Artificial Intelligence-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically Enhanced Deep Learning.

Serotonergic Signaling in Gastric Physiology and Motility Disorders.

Construction of cell factories, and multi-enzymatic and chemoenzymatic cascades to enable the efficient production of alkaloids.

Total Synthesis of ent-Kaurenoic Acid Diterpenoids Enabled by Distal Conformational Control in Photoredox Radical Polyene Cyclization.

Semisynthetic diversification of the fungal azaphilone austdiol highlights scaffold-encoded reactivity in natural products.

Highly fluorescent and solvatochromic phenazine-diamines: the role of non-conjugating substituents.

Carrier-free self-assembled nanoparticles derived from traditional Chinese medicine active components: construction strategies and applications.

Related Experiment Videos

Designer drugs for inflammatory bowel disease

Related Concept Videos

Related Articles